ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 110 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,640 | -8.1% | 5,162 | 0.0% | 0.00% | – |
| Q2 2023 | $8,311 | -44.5% | 5,162 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $14,970 | -21.5% | 5,162 | -11.2% | 0.00% | 0.0% |
| Q4 2022 | $19,076 | +56.7% | 5,816 | +80.6% | 0.00% | 0.0% |
| Q3 2022 | $12,172 | -72.4% | 3,220 | -43.2% | 0.00% | -50.0% |
| Q2 2022 | $44,138 | -16.1% | 5,666 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $52,637 | -85.2% | 5,666 | -74.9% | 0.00% | -60.0% |
| Q4 2021 | $356,113 | -12.0% | 22,596 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $404,468 | +15.1% | 22,596 | 0.0% | 0.01% | +20.0% |
| Q2 2021 | $351,368 | +20.3% | 22,596 | +11.1% | 0.01% | +25.0% |
| Q1 2021 | $292,054 | -30.3% | 20,338 | -4.7% | 0.00% | -33.3% |
| Q4 2020 | $418,963 | +51.5% | 21,343 | 0.0% | 0.01% | +20.0% |
| Q3 2020 | $276,605 | +1.7% | 21,343 | +14.3% | 0.01% | 0.0% |
| Q2 2020 | $271,978 | +109.4% | 18,667 | +22.3% | 0.01% | +66.7% |
| Q1 2020 | $129,905 | -46.3% | 15,265 | +3.9% | 0.00% | -25.0% |
| Q4 2019 | $242,010 | +9.5% | 14,694 | -6.1% | 0.00% | 0.0% |
| Q3 2019 | $220,950 | -17.6% | 15,648 | +17.3% | 0.00% | -20.0% |
| Q2 2019 | $268,288 | -49.4% | 13,341 | 0.0% | 0.01% | -50.0% |
| Q1 2019 | $530,305 | +11.0% | 13,341 | -3.0% | 0.01% | 0.0% |
| Q4 2018 | $477,779 | -13.1% | 13,753 | +3.4% | 0.01% | 0.0% |
| Q3 2018 | $550,079 | -99.9% | 13,303 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $488,886,000 | +18.4% | 13,303 | +25.6% | 0.01% | +33.3% |
| Q1 2018 | $412,932,000 | +245692.9% | 10,588 | +14.1% | 0.01% | +200.0% |
| Q4 2017 | $168,000 | -42.7% | 9,283 | -47.6% | 0.00% | 0.0% |
| Q3 2017 | $293,000 | +18.1% | 17,716 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $248,000 | -31.9% | 17,716 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $364,000 | +44.4% | 17,716 | 0.0% | 0.00% | +50.0% |
| Q4 2016 | $252,000 | -33.5% | 17,716 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $379,000 | -5.0% | 17,716 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $399,000 | +75.0% | 17,716 | +48.1% | 0.00% | +50.0% |
| Q1 2016 | $228,000 | -27.8% | 11,960 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $316,000 | -16.0% | 11,960 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $376,000 | -30.5% | 11,960 | +16.6% | 0.00% | -25.0% |
| Q2 2015 | $541,000 | – | 10,256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
| Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
| Arctis Global LLC | 397,046 | $587,628 | 0.32% |
| Baupost Group | 9,773,616 | $14,465 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
| MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
| 683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
| STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
| WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |